Online survey on existing sarcoidosis registries and biobanks: an ERN lung initiative.
Main Article Content
Keywords
sarcoidosis, Registries, Biobank
Abstract
The present survey, promoted by the European Reference Network on rare respiratory diseases (ERN-Lung, Core Networks Sarcoidosis and ILD), aims to assess the existing sarcoidosis registries and biobanks across Europe and to compare the various types of biospecimen collected, the different procedures performed, and the sample storage conditions applied.
This survey was initiated by the European Reference Network on rare respiratory diseases (ERN-Lung) Core Network “Sarcoidosis” in April 2023. The survey was launched by ERN-Lung Core Network “Sarcoidosis” in August 2023 and remained active until end of February 2024. It was disseminated to all ERN-Lung Core Network “Sarcoidosis” members (first round) and to “ILD” CN members (second round) via mail. Consent to completing the questionnaire was expressly requested before starting the online procedure.
This survey raises important questions about future developments. The creation of registries and biobanks specific for sarcoidosis is mandatory to improve the knowledge of sarcoidosis pathogenesis and its management.
This survey shows that the map of registries and biobanks specific for sarcoidosis in Europe is fragmented and needs merging, funding and coordination to allow high quality and structured research in sarcoidosis.
References
2. Gerke AK, Tang F, Cozier YC, et al. A web-based registry for patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):26–34.
3. Møller J, Hilberg O, Bendstrup E. Design and rationale of ProSar, the first Danish sarcoidosis registry. Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021044.
4. Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 Apr 15;201(8):e26–51.
5. Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021 Dec 16;58(6):2004079.
6. ERN-LUNG | Rare Respiratory Diseases [Internet]. [cited 2024 May 28]. How to join ERN-LUNG. Available from: https://ern-lung.eu/for-clinicians/join-ern-lung/
7. Mortaz E, Gudarzi H, Tabarsi P, et al. Flow cytometry applications in the study of immunological lung disorders. Iran J Allergy Asthma Immunol. 2015 Feb;14(1):12–8.
8. Magallon RE, Harmacek LD, Arger NK, et al. Standardization of flow cytometry and cell sorting to enable a transcriptomic analysis in a multi-site sarcoidosis study. PLoS One. 2023;18(3):e0281210.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
